Abstract
Brassinin and cyclobrassinin are phytoalexins produced by plants of the family Brassicaceae. An overview of the chemistry of these phytoalexins, metabolism, biological activity and applications of current knowledge that could contribute to the sustainability of crucifer crop production is provided.
Keywords: Biosynthesis, biotransformation, Brassicaceae, brassinin, crucifer, cyclobrassinin, paldoxin, phytoalexin.
Graphical Abstract
The Natural Products Journal
Title:Chemistry and Biology of the Cruciferous Phytoalexins Brassinin and Cyclobrassinin
Volume: 4 Issue: 3
Author(s): M. Soledade C. Pedras
Affiliation:
Keywords: Biosynthesis, biotransformation, Brassicaceae, brassinin, crucifer, cyclobrassinin, paldoxin, phytoalexin.
Abstract: Brassinin and cyclobrassinin are phytoalexins produced by plants of the family Brassicaceae. An overview of the chemistry of these phytoalexins, metabolism, biological activity and applications of current knowledge that could contribute to the sustainability of crucifer crop production is provided.
Export Options
About this article
Cite this article as:
Pedras Soledade C. M., Chemistry and Biology of the Cruciferous Phytoalexins Brassinin and Cyclobrassinin, The Natural Products Journal 2014; 4 (3) . https://dx.doi.org/10.2174/2210315504666141016222025
DOI https://dx.doi.org/10.2174/2210315504666141016222025 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis of New N1Arylpiperazine Substituted Xanthine Derivatives and Evaluation of their Antioxidant and Cytotoxic Effects
Anti-Cancer Agents in Medicinal Chemistry GCH1, BH4 and Pain
Current Pharmaceutical Biotechnology The Association of Chemotherapy and Radiotherapy in Squamous Cell Carcinoma of Anal Canal
Current Drug Therapy Pharmacological Drug Delivery Strategies for Improved Therapeutic Effects: Recent Advances
Current Pharmaceutical Design Enhanced Activity of pSTAT-3 Ser-727 in Functional Endothelial Cells Under Calcifying Conditions
Current Chemical Biology Biology and Impact of Signal Transducers and Activators of Transcription and Their Regulators as Targets in Cancer Therapy
Current Signal Transduction Therapy Natural Compounds as Antagonists of Canonical Wnt/β-Catenin Signaling
Current Chemical Biology Strategies for the Biological Evaluation of Gold Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Anti-Breast Cancer Agents from Chinese Herbal Medicines
Mini-Reviews in Medicinal Chemistry Anti-diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy
Current Cancer Drug Targets Novel Mast Cell-Stabilising Amine Derivatives of 3,4-Dihydronaphthalen-1(2H)-one and 6,7,8,9-Tetrahydro-5H-benzo[7]annulen-5-one
Medicinal Chemistry Oncogenic MicroRNA-27a is a Target for Genistein in Ovarian Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Adenovirus-Based Cancer Gene Therapy
Current Gene Therapy Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets The Function of the Selective Inhibitors of Cycloxygenase 2
Mini-Reviews in Medicinal Chemistry Determination of Dysregulated miRNA Expression Levels by qRT-PCR after the Application of Usnic Acid to Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Electroporation in DNA Vaccination Protocols Against Cancer
Current Drug Metabolism Driving Cellular Plasticity and Survival Through the Signal Transduction Pathways of Metabotropic Glutamate Receptors
Current Neurovascular Research Immune Checkpoint Inhibitors in the Treatment of Cancer
Current Reviews in Clinical and Experimental Pharmacology Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Current Pharmaceutical Design